Illustrative image – not actual.Torrent Pharmaceuticals has commissioned a 3,000 sq mtrs insulin vial manufacturing unit at its existing facility in Mehsana district of Gujarat for exclusive sales to Danish company Novo Nordisk.
The facility has been set up at a cost of $11 million (approx Rs 50.6 crore) and has a capacity of 26 million insulin vials with the possibility of increasing its capacity by 20-30 per cent after three to four years.
Torrent is investing Rs 350 crore in its formulations facility at Dahej SEZ to be commissioned in three years for exports to regulated markets such as the US and Europe.
Meanwhile, the company's tablet manufacturing facility project in Sikkim is on track and likely to start commercial production from the middle of next fiscal. The company has invested around Rs 125 crore on the facility spread over six acre.
Also See:
